Chest ACCP Education Calendar
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by FINKEL, S.
Right arrow Articles by SULLIVAN, B. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by FINKEL, S.
Right arrow Articles by SULLIVAN, B. H., JR.
(Chest. 1952;21:55-69.)
© 1952 American College of Chest Physicians

Primary Atypical Pneumonia

An Analysis of One Hundred Twenty-Three Cases; Report of One Fatality; Review of Fourteen Cases Treated with Aureomycin.

SIDNEY FINKEL M.D.1 and B. H. SULLIVAN JR. M.C.1

1 Station Hospital, Fort Dix, New Jersey

1) One hundred and twenty three cases with clinical diagnosis of primary atypical pneumonia seen over a three month period, one case history with necropsy findings, and 14 cases treated with aureomycin are reported.

2) The serological, pathological, and roentgenographic findings seen in primary atypical pneumonia are reviewed.

3) Aureomycin has been found to be of definite therapeutic value in treating patients who are acutely ill with primary atypical pneumonia. Temperatures return to normal in 18 to 60 hours accompanied by marked symptomatic improvement. In the few cases observed, resolution of the pulmonary findings on roentgenogram is accelerated, and the duration of hospitalization is shortened. Two cases treated with aureomycin had relapses 10 days and two weeks respectively following chemotherapy; roentgenographic clearing and return to normal occurred on symptomatic therapy in these two patients.






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1952 by the American College of Chest Physicians.